Breaking News

SCI Offers China-based Compliance Audit Services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sancilio & Company, Inc. (SCI) has established 21 CFR Part 210/211 Compliance Auditing Services for drug manufacturers importing materials, supplies, products and excipients from Asia. The new service is based in Shanghai. According to Fred D. Sancilio, Ph.D., chief executive officer and chief scientist of SCI, “Recent quality issues discovered in a variety of products from Asia are urging U.S. companies to increase their vigilance in quality while importing when importing materials fro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters